Clonal evolution in chronic lymphocytic leukemia: Analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance. Issue 10 (26th July 2013)
- Record Type:
- Journal Article
- Title:
- Clonal evolution in chronic lymphocytic leukemia: Analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance. Issue 10 (26th July 2013)
- Main Title:
- Clonal evolution in chronic lymphocytic leukemia: Analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance
- Authors:
- López, Cristina
Delgado, Julio
Costa, Dolors
Villamor, Neus
Navarro, Alba
Cazorla, Maite
Gómez, Cándida
Arias, Amparo
Muñoz, Concha
Cabezas, Sandra
Baumann, Tycho
Rozman, María
Aymerich, Marta
Colomer, Dolors
Pereira, Arturo
Cobo, Francesc
López‐Guillermo, Armando
Campo, Elías
Carrió, Ana - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder characterized with highly variable clinical course. The most common chromosomal abnormalities in CLL, using conventional and molecular cytogenetics, are trisomy 12, del(13)(q14), del(11)(q22–23), del(17)(p13), and del(6)(q21). Whereas the prognostic marker such as <italic>IGHV</italic> mutational status remains stable during course of the diseases, chromosomal aberrations may be acquired over time. The aim of this study was to determine the incidence, and biological significance of clonal evolution (CE) using conventional and molecular cytogenetics and its relationship with prognostic markers such as CD38, ZAP70, and the mutational status of <italic>IGHV</italic> and <italic>NOTCH1</italic>. One hundred and forty‐three untreated CLL patients were included in the study. The median time interval between analyses was 32 months (range 6–156 months). Forty‐seven patients (33%) had CE as evidenced by detection of new cytogenetic abnormalities during follow‐up. CE was not correlated with high expression of ZAP70, unmutated <italic>IGHV</italic> genes or <italic>NOTCH1</italic> mutations. Multivariate analysis revealed that CE and <italic>IGHV</italic> mutation status had a significant impact on TFS. The combination of conventional and molecular cytogenetics increased the detection of CE, this phenomenon probably being a<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder characterized with highly variable clinical course. The most common chromosomal abnormalities in CLL, using conventional and molecular cytogenetics, are trisomy 12, del(13)(q14), del(11)(q22–23), del(17)(p13), and del(6)(q21). Whereas the prognostic marker such as <italic>IGHV</italic> mutational status remains stable during course of the diseases, chromosomal aberrations may be acquired over time. The aim of this study was to determine the incidence, and biological significance of clonal evolution (CE) using conventional and molecular cytogenetics and its relationship with prognostic markers such as CD38, ZAP70, and the mutational status of <italic>IGHV</italic> and <italic>NOTCH1</italic>. One hundred and forty‐three untreated CLL patients were included in the study. The median time interval between analyses was 32 months (range 6–156 months). Forty‐seven patients (33%) had CE as evidenced by detection of new cytogenetic abnormalities during follow‐up. CE was not correlated with high expression of ZAP70, unmutated <italic>IGHV</italic> genes or <italic>NOTCH1</italic> mutations. Multivariate analysis revealed that CE and <italic>IGHV</italic> mutation status had a significant impact on TFS. The combination of conventional and molecular cytogenetics increased the detection of CE, this phenomenon probably being a reflection of genomic instability and conferring a more aggressive clinical course. © 2013 Wiley Periodicals, Inc.</p> </abstract> … (more)
- Is Part Of:
- Genes, chromosomes & cancer. Volume 52:Issue 10(2013:Oct.)
- Journal:
- Genes, chromosomes & cancer
- Issue:
- Volume 52:Issue 10(2013:Oct.)
- Issue Display:
- Volume 52, Issue 10 (2013)
- Year:
- 2013
- Volume:
- 52
- Issue:
- 10
- Issue Sort Value:
- 2013-0052-0010-0000
- Page Start:
- 920
- Page End:
- 927
- Publication Date:
- 2013-07-26
- Subjects:
- Cancer -- Genetic aspects -- Periodicals
616.994042 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2264 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/gcc.22087 ↗
- Languages:
- English
- ISSNs:
- 1045-2257
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4111.763000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3991.xml